UNSPSC 85816322: Introduction of oxazolidinones into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E03328

UNSPSC 85816322 Introduction of oxazolidinones into peripheral vein, percutaneous approach is a Commodity code that describes a specific pharmaceutical administration procedure, yet recent state and local procurement activity under this code shows little alignment with the technical scope — instead, the opportunities posted reflect broad healthcare service categories spanning telehealth, medical operations, behavioral health, and occupational medicine that do not involve oxazolidinone infusion. The issuing bodies soliciting under or near this code include large county health systems (Inland Empire Health Plan in California, DeKalb County in Georgia, Santa Clara County in California), state health authorities (Nevada Health Authority), and public hospitals (San Mateo Medical Center), indicating that the code may be misapplied in state and local procurement systems or that the recent activity reflects general healthcare contracting rather than the specific clinical procedure the code nominally describes.

The recent opportunities posted under or adjacent to this code span virtual urgent care (Inland Empire Health Plan RFI, October 31 response deadline), Program of All Inclusive Care for the Elderly (PACE) operations across Nevada (RFP 41NHA-S4038, December 10 response deadline with fixed monthly capitation ranging from $4,532.24 to $8,804.32 per participant depending on service area and eligibility), cancer registry services at San Mateo Medical Center (RFP, October 12 response deadline with approximately 1,000 annual cases), and handheld retinal screening devices and services at San Mateo Medical Center (RFP, November 6 response deadline). Geographic activity clusters in California (San Mateo County, Inland Empire region) and Nevada, with additional opportunities in Georgia and Colorado. Given the mismatch between the code's clinical definition and the actual services being procured—none of which involve direct pharmaceutical administration—this Commodity code shows minimal relevant recent state and local procurement activity; the postings appear to reflect broad healthcare service categorization rather than specific oxazolidinone infusion procedures.